Ana Oliveira Hoff
Universidade de São Paulo
H-index: 38
Latin America-Brazil
Top articles of Ana Oliveira Hoff
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Not Only RET but NF1 and Chromosomal Instability Are Seen in Young Patients with Sporadic Medullary Thyroid Carcinoma | Journal of the Endocrine Society | Luciana Audi Castroneves Flavia Regina Rotea Mangone Antonio Marcondes Lerario Ana Maria da Cunha Mercante Rafael Loch Batista | 2024/6 |
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular … | Thyroid | Jaume Capdevila Jolanta Krajewska Jorge Hernando Bruce Robinson Steven I Sherman | 2024/1/23 |
Differentiated thyroid carcinoma: what the nonspecialists needs to know | Ana O Hoff Aline Lauda Freitas Chaves Thiago Bueno de Oliveira Helton Estrela Ramos Gustavo Cancela Penna | 2024 | |
Intraoperative radiofrequency ablation for unresectable abdominal paraganglioma: a case report | Frontiers in Endocrinology | Isabelle PA Magalhaes Bibiana D Boger Nathalia L Gomes Guilherme LP Martins Leomarques A Bomfim Jr | 2024/4/15 |
Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective | Fabian Pitoia Rafael Selbach Scheffel Ines Califano Alicia Gauna Hernán Tala | 2024/2 | |
Evidence for a Founder Effect of SDHB Exon 1 Deletion in Brazilian Patients With Paraganglioma | The Journal of Clinical Endocrinology & Metabolism | Gustavo FC Fagundes Felipe Freitas-Castro Lucas S Santana Ana Caroline F Afonso Janaina Petenuci | 2023/8 |
604P Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer who progressed after prior VEGFR-targeted therapy: Outcomes from COSMIC … | Annals of Oncology | MS Brose B Keam B Robinson S Sherman JA Krajewska | 2023/11/1 |
Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study) | Clinics | Marcos Tadashi Kakitani Toyoshima Priscilla Cukier Aline Santos Damascena Rafael Loch Batista Fernanda de Azevedo Correa | 2023/8/21 |
Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A Review | Robert Haddad Rossella Elisei Ana O Hoff Zhiyan Liu Fabian Pitoia | 2023/6/8 | |
LBA3 Randomized phase III study of selpercatinib versus cabozantinib or vandetanib in advanced, kinase inhibitor-naïve, RET-mutant medullary thyroid cancer | Annals of Oncology | J Hadoux R Elisei MS Brose A Hoff B Robinson | 2023/10/1 |
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer | New England Journal of Medicine | Julien Hadoux Rossella Elisei Marcia S Brose Ana O Hoff Bruce G Robinson | 2023/11/16 |
Ultrasound in cervical traumatic neuromas after neck dissection in thyroid carcinoma patients: descriptive analysis and diagnostic accuracy | Archives of endocrinology and metabolism | Vinicius Neves Marcos Debora Lucia Seguro Danilovic Fernando Linhares Pereira Miriam Harumi Tsunemi Marco Aurelio Vamondes Kulcsar | 2023/6/5 |
SAT307 Intraoperative Radiofrequency Ablation Of An Unresectable Abdominal Paraganglioma Promoted Objective Tumor Response And Complete Biochemical Remission | Journal of the Endocrine Society | Isabelle PA de Magalhães Bibiana S Boger Nathalia LRA Gomes Guilherme LP Martins Leomarques A Bomfim | 2023/10 |
Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM) | Archives of Endocrinology and Metabolism | Laura Sterian Ward Rafael Selbach Scheffel Ana O Hoff Carolina Ferraz Fernanda Vaisman | 2022/9/30 |
Cabozantinib (C) versus placebo (P) in patients (pts) with radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC) who have progressed after prior VEGFR-targeted … | Jorge Hernando Jaume Capdevila Bruce Robinson Steven I Sherman Barbara Jarząb | 2022/6/1 | |
Cabozantinib for previously treated radioiodine‐refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC‐311 trial | Cancer | Marcia S Brose Bruce G Robinson Steven I Sherman Barbara Jarzab Chia‐Chi Lin | 2022/12/15 |
How to Identify Cervical Traumatic Neuromas in the Post-operative Neck Dissection: Brief Review of the Cervical Plexus Ultrasound | Vinícius Neves Marcos Marco Aurelio Vamondes Kulcsar Ana Oliveira Hoff Maria Cristina Chammas Ricardo Miguel Costa de Freitas | 2022/9/1 | |
Cytoreductive surgery of the primary tumor in metastatic adrenocortical carcinoma: impact on patients’ survival | The Journal of Clinical Endocrinology & Metabolism | Victor Srougi Irina Bancos Marilyne Daher Jeffrey E Lee Paul H Graham | 2022/4/1 |
Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study | einstein (São Paulo) | Marcos Tadashi Kakitani Toyoshima Priscilla Cukier Alexandre Barbosa Câmara de Souza Juliana Pereira Ana Oliveira Hoff | 2022/7/8 |
1653P Cabozantinib (C) vs placebo (P) in patients (pts) with radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC) who progressed after prior VEGFR-targeted therapy … | Annals of Oncology | MS Brose JA Krajewska F Vaisman AO Hoff E Hitre | 2022/9/1 |
Co-Authors
